Cas:327092-81-9 AKR1C3-IN-1 manufacturer & supplier

We serve Chemical Name:AKR1C3-IN-1 CAS:327092-81-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

AKR1C3-IN-1

Chemical Name:AKR1C3-IN-1
CAS.NO:327092-81-9
Synonyms:3-(2-1,2,3,4-tetrahydroisoquinolylsulfonyl)benzoic acid;3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic acid;3-(3,4-Dihydro-1H-isoquinoline-2-sulfonyl)-benzoic acid;AKR1C3-IN-1
Molecular Formula:C16H15NO4S
Molecular Weight:317.36000
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:83.06000
Exact Mass:317.07200
LogP:3.15050

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(2-1,2,3,4-tetrahydroisoquinolylsulfonyl)benzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AKR1C3-IN-1 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(3,4-Dihydro-1H-isoquinoline-2-sulfonyl)-benzoic acid Use and application,3-(2-1,2,3,4-tetrahydroisoquinolylsulfonyl)benzoic acid technical grade,usp/ep/jp grade.


Related News: “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. (2R)-3-(4′-indol-1-ylbiphenyl-4-ylmethylsulfanyl)-2-isobutoxycarbonylamino-propionic acid manufacturers A thorough safety and risk analysis procedure should be administered at an appropriate time with documentation that adheres to the rules and regulations set forth by the regulatory authorities. [(η5-indenyl)Pd(Cl)(P(OMe)3)] suppliers The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. isopropyl 4-(N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)sulfamoyl)thiophene-3-carboxylate vendor & factory.